New Key Statistics Module, Z-Score and F-Score
NAS:FHTX Key Ratios
| Market Cap $ M | 409.43 |
| Enterprise Value $ M | 174.02 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 9.18 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 35.00 |
| EPS (TTM) $ | -1.95 |
| Beneish M-Score | -1.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -8.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.83 |
| EV-to-EBITDA | -1.90 |
| PEG | -- |
| Shares Outstanding M | 55.33 |
| Net Margin (%) | -245.69 |
| Operating Margin % | -269.91 |
| Pre-tax Margin (%) | -237.95 |
| Quick Ratio | 5.69 |
| Current Ratio | 5.69 |
| ROA % (ttm) | -28.39 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -110.95 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.32 |
FHTX Number of Guru Trades
FHTX Volume of Guru Trades
Gurus Latest Trades with NAS:FHTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FHTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Foghorn Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FHTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers